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Abstract
Cholera is a severe, water-borne diarrhoeal disease caused by toxin-producing strains of the bacterium Vibrio cholerae.
Comparative genomics has revealed ‘waves’ of cholera transmission and evolution, in which clones are successively
replaced over decades and centuries. However, the extent of V. cholerae genetic diversity within an epidemic or even within
an individual patient is poorly understood. Here, we characterized V. cholerae genomic diversity at a micro-epidemiological
level within and between individual patients from Bangladesh and Haiti. To capture within-patient diversity, we isolated
multiple (8 to 20) V. cholerae colonies from each of eight patients, sequenced their genomes and identified point mutations
and gene gain/loss events. We found limited but detectable diversity at the level of point mutations within hosts (zero to
three single nucleotide variants within each patient), and comparatively higher gene content variation within hosts (at least
one gain/loss event per patient, and up to 103 events in one patient). Much of the gene content variation appeared to be due
to gain and loss of phage and plasmids within the V. cholerae population, with occasional exchanges between V. cholerae and
other members of the gut microbiota. We also show that certain intra-host variants have phenotypic consequences. For
example, the acquisition of a Bacteroides plasmid and non-synonymous mutations in a sensor histidine kinase gene both
reduced biofilm formation, an important trait for environmental survival. Together, our results show that V. cholerae is
measurably evolving within patients, with possible implications for disease outcomes and transmission dynamics.
DATA SUMMARY
1. Illumina sequence data have been deposited in the NCBI
Sequence Reads Archive (SRA) under BioProject
PRJNA400505. Individual sample accession numbers are
listed in Table S1 (available in the online version of this
article).
2. Assemblies are available from a GitHub repository
(https://github.com/ilevade/Vibrio_cholerae_within_patient_
assemblies).
INTRODUCTION
Cholera is an acute diarrhoeal infection that remains a serious
health threat in countries with limited access to clean water
[1]. Vibrio cholerae is the causative agent of the disease and is
a natural inhabitant of aquatic ecosystems [2], with more
than 200 serogroups identified to date on the basis of their
somatic O antigens [3, 4]. Most V. cholerae serogroups are
not pathogenic; only isolates in serogroup O1 (consisting of
two biotypes known as ‘classical’ and ‘El Tor’ and the sero-
types Ogawa and Inaba) and O139 have been identified as
agents of cholera epidemics and pandemics [1].
Whole genome sequencing and population genomics have
the potential to improve our understanding of the epidemi-
ology, aetiology and evolution of bacterial infectious dis-
eases [5]. For example, comparisons of whole-genome
sequences of strains of V. cholerae from across the world,
over the course of a century, clarified the history of the
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current pandemic [6] and showed that this pandemic is the
result of a single clonal expansion of one V. cholerae O1 El
Tor ancestor, accompanied by horizontal gene transfer
(HGT) events involving toxin and antibiotic resistance
genes [7]. More recently, comparative genomics has been
applied to answer epidemiological questions, proving the
Asian origin of the strain causing the ongoing Haitian chol-
era outbreak, which began in 2010 [8–11]. Using whole
genome sequencing and single nucleotide polymorphism
(SNP) analysis, Azarian et al. [12] compared 60 clinical and
environmental isolates collected in Haiti from 2010 to 2012.
They found that the 2011 and 2012 strains rapidly diverged
from the 2010 ancestral strain that initiated the outbreak,
suggesting evolution driven by positive selection in a new
environment [12].
Viral pathogens can evolve and diversify within infected
patients, with serious consequences for disease outcome [13],
and certain bacterial pathogens have recently been shown to
diversify within patients as well [14]. However, evolutionary
and epidemiological studies have conventionally been con-
ducted with just one bacterial isolate taken as representative
of the infection, even though within-patient diversity is
important to consider, for several reasons [15–18]. Within-
host evolution may impact the longer-term evolution and
transmission potential of pathogens, particularly if there are
fitness trade-offs between evolution within and between
hosts. For example, a study of one cholera patient from Haiti
showed that phage-resistant V. cholerae mutants rose to high
frequency within the patient due to positive selection imposed
by phage predation [19]. The study showed how strong selec-
tion can shape V. cholerae diversity within patients, but the
prevalence and extent of V. cholerae genetic diversity within
patients remains unclear and also whether intra-host evolu-
tion is generally driven by selection.
As for many other bacterial pathogens, the prevailing ortho-
doxy is that V. cholerae infections are essentially clonal, and
essentially devoid of within-host genetic diversity. Although
within-host populations of V. cholerae have not been stud-
ied extensively, evidence suggests that within-host diversity
does indeed exist, at the level of phase variation in the O
antigen, or in variable number tandem repeat (VNTR) loci
[4, 20]. This diversity could arise by within-host evolution,
or be due to infection by different strains that diverged
before entering the host. V. cholerae is genetically diverse in
aquatic ecosystems [21] and co-infections from diverse envi-
ronmental strains are possible [22]. V. cholerae infections
are acute, lasting only a few days before the patient either
recovers or dies [1]. Therefore, there is limited time for
within-host evolution (including mutation, recombination
and selection) to occur. On the other hand, measurable
within-host evolution has been demonstrated over just 6
days in a Burkholderia pseudomallei infection [23]. It is
therefore expected that even if V. cholerae will experience
less within-host evolution compared to more chronic bacte-
rial infections with documented within-host evolution [24–
29], diversity among isolates from the same patient could be
detectable. Indeed, V. cholerae grows to large population
sizes within the host (from 107 to 109 vibrios per gram of
stool), dominating the gut microbiome [30, 31]. If the effec-
tive population size within a host is large, many mutations
are expected and natural selection will be efficient. However,
V. cholerae likely experiences population bottlenecks upon
infection and within the gut [32], which would reduce
genetic diversity and reduce the efficiency of selection. In
addition to point mutations, V. cholerae can undergo high
rates of HGT [7, 33, 34], providing an additional potential
source of within-host diversity. During an infection, V. chol-
erae could acquire genes from plasmids, phages, pathogenic-
ity islands or genes from the gut microbiota, which appears
to be a hot-spot of HGT [35]. However, the extent of
within-patient mutation, HGT and natural selection are still
poorly known for V. cholerae.
In this study, we characterized genomic diversity of V. chol-
erae within and between eight cholera patients, sequencing
between eight and 20 isolate genomes per patient. We iden-
tified both intra-host single nucleotide variants (iSNVs) and
gene gain/loss events within patients. As expected for an
acute infection, few within-patient point mutations were
detected, ranging from zero to three iSNVs per host. In con-
trast, we found a substantial amount of gene content varia-
tion: between five and 103 gene gains or losses within each
patient. We suggest that most diversity is due to within-host
IMPACT STATEMENT
Certain bacterial pathogens can evolve and diversify
within the human host, often altering virulence and anti-
biotic resistance. However, most examples of within-host
evolution have come from chronic infections, in which
the pathogen has sufficient time to mutate and diversify,
and little attention has been paid to more acute infections
such as the one caused by V. cholerae. By sequencing
multiple bacterial isolates from each of eight patients
from Bangladesh and Haiti, we found that cholera
patients can harbour a diverse population of V. cholerae.
As expected for an acute infection, this diversity is lim-
ited, ranging from zero to three point mutations (single
nucleotide variants) per patient. However, gene gain/loss
events are more prevalent than point mutations, occur-
ring in every single patient, and sometimes involving the
transfer of dozens of genes on plasmids. Even if rare,
point mutations and gene gain/loss events may be main-
tained by natural selection, and can alter clinically- and
environmentally-relevant phenotypes such as biofilm
formation. Therefore, within-patient evolution has the
potential to impact clinical and epidemiological out-
comes. Together, our results demonstrate that within-
patient evolution may be a general feature of both acute
and chronic infections, and that gene gain/loss may be
an important feature of within-host evolution.
Levade et al., Microbial Genomics 2017;3
2
mutation rather than co-infection, and that HGT of mobile
elements is more common than point mutations. In most
patients, within-host evolution can be explained by neutral
mutation, recombination and bottlenecks; however, one
patient showed evidence for diversification driven by posi-
tive selection, resulting in phenotypic variation among
intra-host V. cholerae isolates in their ability to form bio-
films. Despite the relatively small numbers of mutations and
HGT events within hosts, these events may have important
evolutionary and phenotypic consequences for V. cholerae
populations.
METHODS
Enrolment
To study cholera within-host diversity, stool samples were
collected from five patients (B1 to B5) from Dhaka, Bangla-
desh, and three patients (H1 to H3) from Artibonite, Haiti.
Between eight and 20 V. cholerae colonies were isolated
from each patient, as described below. Patients in Bangla-
desh were enrolled at the icddr,b (International Center for
Diarrheal Disease Research, Bangladesh) Dhaka Hospital.
In Haiti, samples were collected from patients presenting to
St. Marc’s Hospital, Arbonite with acute watery diarrhoea in
April 2013. See the Supplementary Methods for more details
on sample collection.
In addition to these eight patients, we included 21 ‘Time
Course’ patients (TC01 to TC21) from a surveillance pro-
gram conducted by the icddr,b, between 2011 and 2013. For
the Time Course samples, only one isolate was sequenced
per patient.
Sample processing
Stools from both Haiti and Bangladesh were stored at Mas-
sachusetts General Hospital (MGH) at  80

C and then
streaked directly onto thiosulfate-citrate-bile salts-sucrose
agar (TCBS), a medium selective for V. cholerae. After over-
night incubation, 20 well-separated colonies were inoculated
into 5ml Luria-Bertani broth and grown at 37

C overnight.
For each colony, 1ml of broth culture was stored at  80

C
with 30% glycerol until DNA extraction. For patient 1, one
of the colonies was re-streaked on a new TCBS plate and 12
colonies were selected as a control for culture-induced arte-
facts and sequencing errors. Bacterial stocks made from a
single colony were grown in 1.5ml LB media with agitation
at 37

C for 12 h. Colonies were named with a ’C’, followed
by a number; for example, B1C1 corresponds to colony 1
from Bangladesh patient 1. All isolates were identified as
toxigenic V. cholerae O1 biotype El Tor, serotype Ogawa
which was the prevailing serotype at each site during the
entire study period. Genomic DNA was extracted for each
isolate using the Qiagen DNeasy Blood and Tissue kit, using
1.5ml bacteria grown in LB media. In order to obtain pure
gDNA templates, an RNase treatment was followed by a
purification with the MoBio PowerClean Pro DNA Clean-
Up Kit.
Whole genome sequencing
Each isolate was separately sequenced using Illumina tech-
nology to a minimum depth of 28 coverage of the MJ-
1236 reference genome (mean coverage=136). From 122
isolates retrieved from the eight patients, 66 genomic librar-
ies were constructed using the Nextera DNA library kit
(Illumina) according to the manufacturer’s protocol, and
were sequenced with the 250-bp paired-end v2 kit on the
Illumina MiSeq. The remaining 56 libraries were prepared
using the NEBNext Ultra II DNA library prep kit (New
England Biolabs) and sequenced on the Illumina HiSeq
2500 (paired-end 125 bp) at the Genome Quebec sequenc-
ing platform (McGill University). Twelve isolates were
sequenced in replicate using both methods. For details
about isolates, sequencing and assembly see Table S1.
Each genome was de novo assembled, and reads were also
mapped to two closed, annotated V. cholerae reference
genomes. After filtering for errors due to culture and
sequencing (see Supplementary Methods), we identified a
total of 485 high-quality single-nucleotide variants
(hqSNVs) and 22 indels among our 122 isolates, distributed
across the genome (Fig. S1), with a majority of hqSNVs
(471) located in the branch between the Bangladeshi and
the Haitian isolates. Among them, we characterized the
intra-host single nucleotide variants (iSNVs) that varied
among the isolates taken from a single patient (Table 1).
Estimation of effective population sizes (Ne)
To estimate effective population size within each patient, we
used the formula Ne=/2 µ, where Ne is the effective popula-
tion size,  is a measure of genetic diversity and µ is the
mutation rate [36]. We assumed a mutation rate of µ=1/300
per genome per generation [37]. We report the estimated
Ne for each patient in Table S2, using both Waterson’s esti-
mator (W or S) and Tajima’s estimator (T or p) as meas-
ures of genetic diversity. We calculate these estimators as
described by Tajima [36].
Characterization of the flexible genome
From assemblies, we annotated the genomes using the
RAST pipeline [38] with default parameters. Predicted pro-
teins were used as input for the OrthoFinder software [39]
to predict orthologous gene families. These orthologous
gene families were classified into three different categories:
multiple gene families (>1 copy per genome, on average),
single copy genes (exactly one copy per genome) and flexi-
ble genomes (<1 copy per genome). Due to variation in
sequencing coverage and nucleotide composition, genome
assemblies may be incomplete, missing a subset of genes
that are actually present [40, 41]. To address this issue, we
mapped reads back to the full gene catalogue, and consid-
ered a gene to be present when it was covered at 1 (Sup-
plementary Methods; Figs S2 and S3). Potential donors of
horizontally transferred genes were identified using BLAST
against NCBI GenBank, followed by phylogenetic analyses
(Supplementary Methods).
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Phylogenetic evolutionary inference and root-to-tip
regression
For all phylogenetic analyses, we excluded the Integrative
Conjugative Element (ICE), a highly variable 100-kb region
(Fig. S1) that undergoes frequent HGT and thus has a sepa-
rate evolutionary history from the rest of the core genome
[6]. The ICE was defined as the region of MJ1236 chromo-
some 1 located between positions 87 776 and 193 789 (after
reverse-complementation of MJ1236), according to a previ-
ous study [42]. A final alignment of 201 concatenated
hqSNVs was generated from the core genome of the 35 gen-
otypes (TC01–TC21 plus one to four unique genotypes per
patient) and used for phylogenetic analysis. Seaview v.4.5.4
[43] was used to generate a maximum-likelihood phylog-
eny, employing a general time reversible (GTR) substitution
model with four rate classes and subtree pruning and
regrafting (SPR) branch-swapping. All sites being variable
in the alignment, we did not consider the proportion of
invariable sites. To test the degree of temporal structure of
our data we performed a root-to-tip linear regression using
the TempEst software [44], which suggested that our dataset
is sufficiently clock-like to robustly estimate an evolutionary
rate (R2=0.65, P<0.0001; Fig. S4). Substitution rates and
divergence times were then estimated using BEAST v.1.8.3
[45], with XML-input files manually modified to include
both variable and invariable sites, for a total genome the size
of the V. cholerae MJ-1236 reference. The Bayesian tree was
computed and calibrated with sampling dates of the isolates
ranging from March 2011 to December 2013. We compared
different molecular clock and demographic models (Supple-
mentary Methods), and found that the strict molecular
clock and the Bayesian skyline plot models provided the
best fit (Table S3), in accordance with previous studies of
V. cholerae [12, 46].
Tests for violations of neutral evolution
We conducted permutations of the distribution of non-
synonymous, synonymous and intergenic SNVs across sites
in the genome and branches of the phylogeny to identify
any possible deviations from neutral evolution (Supplemen-
tary Methods). To investigate the role of natural selection
within versus between patients, we performed the McDo-
nald–Kreitman test [47] and also conducted permutations
to identify any patients with an excess of non-synonymous
iSNVs compared to random distribution of iSNVs across
patients (Supplementary Methods).
Liquid culture and biofilm growth assays of
isolates from patients H1 and H2
To identify possible phenotypes conferred by the within-
patient variations, we performed in vitro experiments on the
isolates from patient H1 harbouring the three NS point
mutations, and the isolate for which the Bacteroides plasmid
was detected in patient H2. First, to test whether intra-host
variants had any effect on V. cholerae growth in liquid
medium, we measured the growth rates of the variable iso-
lates compared to one isogenic isolate (with inferred ances-
tral alleles and no variation in the flexible genome) from the
same patient. Isolates were grown in 4ml LB broth with agi-
tation at 30

C, and optical densities were measured at
600 nm using a spectrophotometer every hour for 12 h. Sec-
ond, to test for biofilm production, we grew the same iso-
lates in 200 µl LB in a 96-well plate, without agitation at
30

C for 48 h. Controls included empty wells, wells with LB
only, and wells with a V. cholerae isolate with an in-frame
deletion in the gene vpsA (Vibrio polysaccharide A), which
results in reduction of biofilm production [48]. A 0.1%
solution of crystal violet was used to stain for biofilm adher-
ent to the well. Biofilms were dissolved in ethanol at the end
of the assay, and the optical density was measured at
595 nm using spectrophotometry. Experiments were per-
formed in replicates of four to 12.
Polymyxin B MIC assay on patient H1 isolates
Isolates H1C1, H1C5 and H1C6 were grown overnight at
30

C on LB agar and then cultures were diluted 1 : 100 in
fresh LB medium. Cells were grown to mid-exponential
growth and diluted 1 : 10, and an aliquot was plated on LB
agar. Polymyxin B E-test gradient strips (AB Biodisk) were
applied to inoculated plates and incubated at 37

C, and the
minimum inhibitory concentrations (MICs) were evaluated
after 16 h.
RESULTS
Within-patient single nucleotide variation
Among the 485 hqSNVs detected, we found intra-host sin-
gle nucleotide variants (iSNVs) in patients B1, B4, B5 and
H1, from whom we sequenced respectively 19, 17, 20 and 9
isolates (Fig. 1). Isolates from patients B2, B3, H2 and H3
(20, 20, 8 and 9 isolates, respectively) were all isogenic
within patients, with no iSNVs detected using our quality
filters. Patient B1 contained one intergenic iSNV (with an
allele frequency of 1/19), and patients B4 and B5 each con-
tained a synonymous iSNV, each in a different gene (with
respective allele frequencies of 1/17 and 1/20) (Table 1).
Patient H1 contained three iSNV sites, all of which were
non-synonymous, and two of which occurred in the same
gene, a sensor histidine kinase (Table 1), and one of which
was at frequency 2/9, for a total of 4/9 isolates containing
iSNVs (Fig. 1). Twenty-two small insertion/deletions
(indels) were found to vary between patients (and specifi-
cally between patients sampled in different years or different
countries), but we did not detect any indels that varied
within patients.
To ensure that the relatively small number of iSNVs were
not due to mutation during isolate isolation and culture
[49] or sequencing errors, we sub-cultured and sequenced
12 colonies from one isolate (B1C1) as a control (Fig. 1).
Applying the same filters as for SNV discovery in our
patients, we did not detect any iSNVs among control iso-
lates, nor did we detect any SNV differences between repli-
cate libraries prepared and sequenced using different
platforms (Methods). This suggests that the few iSNVs
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identified within patients are unlikely to be culture or
sequencing artefacts.
Based on the number (0–3) and frequencies of iSNVs
per host, we used measures of genetic diversity (W and
p) to estimate within-host effective population size (Ne).
We estimated that Ne within each patient ranged from 0
to 110 (Table S2). Such a small Ne in a bacterial popula-
tion is consistent with a recent population bottleneck,
possibly during host colonization, or a recent selective
sweep having purged most of the diversity within the
population.
Gene gain and loss within and between cholera
patients
To characterize variation in gene content among the 122
sequenced isolates, we analysed orthologous coding sequen-
ces from de novo assemblies. We defined the core genome
as the genes present in all isolates, and the flexible genome
as the genes absent in some of the isolates. We defined a
flexible genome of 155 genes that varied in their presence or
absence across genomes (Methods). Some of these flexible
genes varied in presence/absence within patients, ranging
from five to 103 genes depending on the patient considered
(Table 2, Fig. 2). As two different methods of library con-
struction and sequencing were used in this study, we
sequenced twelve isolates using both methods. Among
them, we observed variation in the detection of the flexible
genome for six of the duplicate sets (Fig. S5), likely because
different library preparation methods may have different
G+C content biases [50]. Using genomes from one method
only (NEBNext/HiSeq), we identified between five and 67
variable genes per patient; using the other method (Nextera/
MiSeq) we identified between zero and 62 genes (Table S4).
In six out of the eight patients studied, the NEBNext/HiSeq
prep identified more within-patient variable genes than the
Fig. 1. Culture and sequencing of isolates of Vibrio cholerae from eight acutely infected patients. To study within-patient evolution,
selective media was used to culture stool samples from five patients from Bangladesh (B1 to B5) and three patients from Haiti (H1 to
H3). Between eight and 20 colonies were isolated from each patient and sequenced separately. For patient B1, we performed a sub-
culture of one isolate (dotted outline) and sequenced 12 of these new isolates as a control for cultured-induced and sequencing arte-
facts. We independently called variants, compared them between isolates within each patient to identify the intra single nucleotide var-
iants (iSNVs, coloured circles) and determined whether they were intergenic (i), synonymous (S), or non-synonymous (NS) mutations.
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Nextera/MiSeq prep. However, for the other two patients,
the Nextera/MiSeq prep detected more variable genes; we
therefore hesitate to draw general conclusions on which
method performed best. When a variable gene is not
detected in a given method, we consider this a false-
negative. We conclude that methodological differences
alone cannot explain the flexible genome variation within
patients, and consider both methods combined for the
remainder of the paper.
Clustering the 155 flexible genes by their presence/absence
profile across patients revealed four distinct categories of
genes (Fig. 2). Category A consists of genes present in
Bangladesh (part of the Bangladesh core genome), but
showing a patchy distribution in Haiti. Category B genes are
fixed (present in all isolates) in patients B1 and B5, and
patchy in other patients. Category C genes are fixed in Haiti
and nearly absent from Bangladesh. Category D genes tend
to be rare, often singletons only observed in a single isolate
within either patient B1 or patient H2.
Several flexible genes corresponded to known mobile
genetic elements. Notably, category A contains 61 gene fam-
ilies (39% of the flexible genome), all located on one single
contig (possibly gained/lost in a single event) corresponding
to a SXT Integrative Conjugative Element (ICE). Category B
encompassed 49 gene families matching Kappa phage pro-
teins. These putative phage genes were clustered together on
large contigs of chromosome 1, and were fixed in patients
B1 and B5 but variable among other patients, some of which
contained complete phage sequences (patients B2 and B3).
Category C contained 15 genes, including some present in
the ICE, which mapped to at least five different contigs
(depending on which isolate’s assembly was considered),
Table 2. Flexible gene content variation within and between patients
Patient No. genes fixed
within patients
No. genes variable
within patients
No.
singletons
B1 111 11 5
B2 61 35 0
B3 61 51 0
B4 61 49 0
B5 111 5 0
H1 14 68 0
H2 14 103 25
H3 14 63 0
Singletons are defined as genes only found in one isolate, and are also
counted as variable genes within patients. Genes fixed within patients
are present in all isolates from a patient, but are absent in at least
one other isolate in the study.
Fig. 2. Presence/absence profile and taxonomic affiliation of gene families in the flexible genome. Red in the heatmap indicates gene
presence; black indicates absence. Each column shows the presence/absence profile for a unique gene family. The heatmap is
ordered by patient along the vertical axis. B1C1 is the control, subcultured from patient B1, and contains no flexible genome variation.
The horizontal axis is ordered by hierarchical clustering, yielding four clusters: A, B, C and D. The taxonomic affiliation of each gene
family (best BLAST hit) is indicated with dots above the heatmap.
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suggesting multiple gain/loss events or frequent
rearrangements.
Over half of the flexible genome (80 genes) was annotated
as hypothetical proteins, compared to the core genome
which contained less than 3% hypothetical proteins. The
flexible genome also contained 10 transposases (6.5% of the
flexible genome, compared to 1.4% of the core) and eight
genes involved in plasmid and viral replication, all potential
mechanisms of HGT [51]. A complete list and annotation
of flexible genes is given in Table S5.
Variation in the flexible gene pool could arise from gene
deletion, duplication, or HGT. To determine the extent of
HGT across species boundaries, we identified the taxonomic
affiliation of each flexible gene according its placement on a
phylogeny of homologs from the GenBank database (Meth-
ods). While the majority (117 out of 155) of flexible genes
were assigned to V. cholerae, several were assigned to non-
cholera vibrios or even distantly related species of Bacter-
oides or Staphylococcus (Fig. 2). These genes had no BLAST
hits to Vibrio, but numerous hits to Bacteroides or Staphylo-
coccus, suggesting HGT from these donors to V. cholerae in
the gut. For example, a group of 20 genes present in isolate
H2C3 (but absent in other isolates from patient H2)
matched a plasmid previously identified in Bacteroides
(Fig. 2). These 20 genes of putative Bacteroides sp. plasmid
origin are among 25 singletons, present in only one isolate
of patient H2. Similarly, the five singletons in patient B1
(Table 2) are all of putative Staphylococcus origin. Each of
these 25 genes are located on a different contig where a sin-
gle gene is predicted, except for two Bacteroides sp. genes,
identified on the same contig. We are therefore unable to
conclude whether the genes are integrated into a V. cholerae
chromosome or as part of a plasmid. Aside from the genes
suspected to have been transferred, no other reads from
genomes of V. cholerae isolates mapped to Staphylococcus
or Bacteroides, suggesting that putative HGT events were
not due to contamination. Together, these results suggest
that most within-patient variation in gene content is due to
gene flow, deletion or duplication within the V. cholerae
population, with rare but detectable HGT from other bacte-
rial species, phages and plasmids in the gut microbiota.
Owing to their low frequencies within patients, these cross-
species HGTs are likely rare and recent events, which may
never achieve high frequency in the V. cholerae population,
either within or across hosts.
V. cholerae evolution on different time scales
In order to place within-host variation in the context of lon-
ger-term V. cholerae evolution, and to distinguish within-
patient mutation from co-infection events, we built a
phylogeny of the 122 isolates (all from 2013) as well as 21
additional isolates obtained from acute cholera patients
sampled in Bangladesh from 2011 to 2013 (Fig. 3). Assum-
ing a constant evolutionary rate across lineages, we esti-
mated the evolutionary rate at 7.9410 7 hqSNV site 1
year 1 [95% highest posterior density (HPD), 4.8910 7 to
1.1410 6] or approximately 3.3 hqSNV year 1 in the core
genome (95% HPD), consistent with previous estimates [6].
We then estimated the ages of the most recent common
ancestors (MRCAs) of the phylogenetic sub-lineages and
clusters (Table S6). Notably, four of the six isolates from
2011 in Bangladesh were found to be closer to the Haitian
isolates than to all the other Bangladeshi isolates (Fig. 3).
We called this sub-lineage BDG-B, and estimated the age of
the MRCA of these four isolates and the Haitian isolates in
September 2005 (95% HPD, June 2002 to July 2008), which
pre-dates the introduction of pathogenic V. cholerae in
Haiti, and is consistent with its Asian origin [10, 11]. The
time of the MRCA of the isolates collected from the three
Haitian patients was estimated at December 2012 (95%
HPD, August 2012 to March 2013).
Based on the phylogeny, we sought to distinguish between
scenarios of within-patient mutation or co-infection as
causes of within-patient diversity. It is clear that isolates
from the same patient always grouped together, and were
never polyphyletic (Fig. 3). This observation is consistent
with each patient being colonized by a single clone, which
subsequently diversified by mutation within the patient.
The diversity between the eight patients (7 SNVs) was
greater than the diversity within patients (0–3 iSNVs),
which would be unlikely if cells of V. cholerae were sampled
by patients at random from an environmental pool
(Table 1). If within-patient diversity was due to co-infection
of the same patient by multiple different strains, we would
expect these strains to share a MRCA before the date of
infection, and certainly before the date of stool sampling.
However, the MRCA of isolates from a single patient always
overlapped with the date of sampling, suggesting that
within-patient diversity is more likely due to within-patient
mutation than to co-infection.
Signatures of natural selection on within-patient
variants
Over 3 years of evolution, we could not reject a neutral evo-
lutionary model and found no evidence for variation in the
NS:S ratio over time, considering only SNVs fixed between
patients (Supplementary Note; Fig. S7). Another possibility
is that selection acts over shorter evolutionary scales, by
shaping intra-host diversity during acute infection. Under
this scenario, we would expect NS:S ratios to differ signifi-
cantly within and between hosts. For example, higher NS:S
within than between hosts could be due to positive or bal-
ancing selection on NS mutations within hosts, or due to
more efficient purifying selection (against deleterious NS
mutations) between hosts. To test for such deviations from
neutral evolution, we applied the McDonald–Kreitman test
[47] to the eight hosts surveyed for within-host genetic vari-
ation (five from Bangladesh and three from Haiti). Despite
the overall low number of SNVs and iSNVs observed, we
found a significant excess of NS mutations between Bangla-
deshi patients (Fisher’s exact test, Odds Ratio >12, P<0.05;
Table 3), suggesting positive selection for the fixation of NS
mutations between patients, or purifying selection against
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NS mutations within patients. In contrast, all three iSNVs
observed in Haiti were NS, suggesting positive, balancing, or
relaxed purifying selection within patients, although not sta-
tistically significant (Fisher’s exact test, Odds Ratio <0.32,
P=1; Table 2).
The three NS iSNVs observed in Haiti all occurred within a
single patient, possibly driven by selective pressures specific
to this patient (Table 1). To test whether this pattern of
iSNVs was likely to have occurred at random or due to
patient-specific selection, we performed permutations of
iSNVs among hosts and estimated expected iSNVs frequen-
cies (F) and number of NS iSNVs per host and region. We
found a significant excess of iSNVs in Haiti (FHTI=0.15;
P<0.05; 10 000 permutations) and in patient H1 (FH1=0.44;
P<0.01), but not in Bangladesh (FBGD=0.03; P>0.05) nor in
any other patients (F=0–0.05; P>0.05). All iSNVs identified
Fig. 3. Bayesian phylogenic tree of 35 V. cholerae genotypes sampled over 3 years in Bangladesh and Haiti. The maximum clade cred-
ibility tree represents the genealogy of sequences in the study, reconstructed from concatenated hqSNVs, using BEAST. Coloured
squares (shades of blue and purple) represent the time-course isolates collected from Bangladeshi patients from March 2011 to
December 2013 (one isolate per patient). Patients for whom we measured intra-host variation (B1–B5 and H1–H3) are shown as
circles. Filled circles indicate the putative ancestral genotype, and empty circles indicate putatively derived iSNVs. The median node
age and divergence date in months and years are indicated at the nodes. The blue bars represent the 95% HPD intervals for diver-
gence time estimates, and posterior probabilities are represented on the branches.
Table 3. McDonald–Kreitman test for differential selection within and between patients
Bangladesh Haiti
Population NS S NS S
Polymorphic (within patient) 0 2 3 0
Fixed (between patients) 5 0 0 0
Fisher exact test, P=0.048 Fisher exact test, P=1
Counts of non-synonymous (NS) and synonymous (S) polymorphic sites (within patient iSNVs) and fixed sites (between patients) for Bangladeshi and
Haitian patients.
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in Haiti and in patient H1 were non-synonymous, which
was significantly higher than expected by chance
(P<0.01 and P<0.001, respectively; Fig. 4). These results
show that patient H1 has a significant excess of NS iSNVs
compared to other patients. This suggests positive or bal-
ancing selection on NS iSNVs within patient H1, or relaxed
purifying selection in patient H1 compared to other
patients.
The three NS iSNVs in patient H1 occurred in two genes.
The first gene, containing one iSNV at position 1 785 021 on
chromosome 1 of the MJ-1236 reference genome (Table 1)
encodes a member of the tetracycline resistance (TetR) fam-
ily of transcriptional regulators (NCBI accession number
ACQ60802.1), known to be involved in the transcriptional
control of multidrug efflux pumps and other pathways like
quorum-sensing circuits or pathogenicity [46, 52]. The
other two NS mutations (positions 2 240 431 and 2 241 580
of chromosome 1) in patient H1 were located in the same
gene (NCBI accession number ACQ61177), a sensor histi-
dine kinase (HK) called vprB, which is required for resis-
tance to the antimicrobial peptide polymyxin B [53]. Each
of these two iSNVs occurs at a different site in the gene,
each in a different isolate. Based on the fact that the major
allele at each of these iSNV sites was present in both refer-
ence genomes (MJ1236 and 2010EL-1786), we inferred that
the minor alleles (both at frequency 1/9 in patient H1;
Table 1) were derived, presumably due to within-patient
mutation. A comparison of the vprB (ACQ61177) protein
sequence with its 465 closest orthologs revealed that the NS
iSNVs modify peptides that are otherwise highly conserved
across species of the genus Vibrio (Fig. S6), suggesting that
these mutations may affect protein function.
Within-patient variants affect biofilm formation
We next asked whether any of the intra-host variants
affected V. cholerae phenotypes. We focused on the non-
synonymous SNVs in vprB which showed a signature of
positive selection in patient H1, and on the plasmid of puta-
tive Bacteroides origin that varied in presence/absence
within patient H2. First, we established that V. cholerae iso-
lates (with or without plasmid, or with ancestral or derived
vprB alleles) did not differ in growth rate in rich medium
(Methods). As loss of vprB function has been previously
associated with increased susceptibility to polymyxin B [53],
we also tested for resistance to the antibiotic polymyxin B,
and again found no difference between isolates. Therefore,
we chose to focus on biofilm formation, a trait which can
impair intestinal colonization but might be beneficial in the
aquatic environment [54, 55], and is readily quantifiable.
Furthermore, it is known that HKs in certain two-compo-
nent systems can affect biofilm formation [56, 57] but the
role of the vprB HK in particular is unknown.
We found that H1C5 and H1C6, the two isolates with
derived alleles in the HK gene vprB, produced significantly
less biofilm than the other isolates from the same patient
(Fig. 5a). Based on our hqSNV calls and flexible gene
Fig. 4. Significant excess of non-synonymous iSNVs in patient H1. (a) Distribution of 122 V. cholerae isolates containing different cate-
gories of iSNVs (I, intergenic; S, synonymous; Nsyn, non-synonymous) or no detectable iSNVs, according to geographic region (BGD,
Bangladesh; HTI, Haiti). Patients from Haiti have a significant excess of Nsyn iSNVs (red; **P0.01; 10 000 random permutations of iso-
lates among regions). (b) Distribution of 122 V. cholerae isolates containing different iSNVs, or no detectable iSNVs, by patient. Patient
H1 has a significant excess of isolates with Nsyn iSNVs (**P0.001; 10 000 random permutations of mutations across patients; Supple-
mentary Methods). NS, not significant.
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analysis, the genome of H1C5 was identical to H1C1, with
the exception of the iSNV in the HK gene. Therefore, the
difference in biofilm phenotypes is attributable to this iSNV.
However, H1C6 differed from H1C1 by an iSNV in the HK
gene, and also by the presence/absence of genes in the flexi-
ble genome (Fig. S5). However, this gene content variation
did not measurably affect biofilm formation (Fig. 5a). In
contrast to the differences in biofilm formation between
vprB alleles, we did not detect any significant difference in
biofilm formation between isolates from patient H1 with
the ancestral iSNV allele (in isolate H1C1) or the derived
allele in the transcriptional regulator gene (isolate H1C4).
In summary, within-patient mutations in vprB, but not
another mutation within the same patient, significantly
reduced the ability of V. cholerae to form biofilms.
In the case of patient H2, we found that the presence of a
plasmid of putative Bacteroides origin reduces biofilm for-
mation even more strongly than point mutations in vprB.
Specifically, the Bacteroides sp. plasmid-containing isolate
(H2C3) produces approximately two-fold less biofilm than
an isogenic control from the same patient (H2C5). The bio-
film formation of H2C3 was indistinguishable from negative
controls (Fig. 5b). Together, these results show that both
point mutations and plasmids segregating within patients
can affect biofilm formation.
DISCUSSION
In this study, we surveyed the genetic diversity of Vibrio
cholerae within infected patients. Using whole-genome
sequencing, we analysed 122 clinical isolates from eight
cholera patients from Bangladesh and Haiti, and demon-
strated that overall levels of within-patient variation are low
for V. cholerae populations compared to more chronic bac-
terial pathogens, which routinely harbour more than 20
iSNVs per patient [25–29, 58]. Even if rare, point mutations
may be under selection within hosts, with phenotypic con-
sequences. For example, we showed that intra-host muta-
tions in a sensor histidine kinase gene reduced biofilm
formation. In addition to point mutations, HGT plays a
major role in Vibrio cholerae evolution and may represent
the major source of genetic diversity, not only in the aquatic
environment, but also in the human host – and with large
effects on phenotypes like biofilm formation. Specifically,
different mutations in a sensor histidine kinase and the
acquisition of a Bacteroides sp. plasmid both reduced the
ability of V. cholerae to form biofilms, which could be
advantageous during host colonization [53, 54].
Gene content variation within patients and its
functional consequences
While HGT is already well-characterized on longer epide-
miological time-scales, we show that it also occurs within
individual patients. V. cholerae is known to undergo HGT
via transformation [59], transduction [60] and conjugation
[61, 62]. HGT contributes substantially to drug resistance,
pathogenicity and adaptation to different environments, via
the acquisition of genomic islands, phages, transposons,
ICEs and plasmids [7, 63]. Our characterization of the flexi-
ble genome within patients used read mapping to confirm
Fig. 5. Biofilm formation of isolates from patients H1 and H2. Optical density at 595 nm was measured for four to 12 replicates of
each isolate, after growth for 48 h at 30

C. Statistical comparisons were made using a non-parametric Mann-Whitney test (*, P<0.05;
***, P<0.0001). Circles represent genomes with either variation in gene content (dark triangle) or iSNV variation (cross). (a) Isolates
from patient H1. Isolate H1C1 represents the ancestral genotype, H1C4 has a non-synonymous mutation in a transcriptional regulator
gene, and H1C5 and H1C6 have different non-synonymous mutations in the same gene, the histidine kinase gene. (b) Isolates from
patient H2. Isolate H2C5 represents the ancestral genotype, with no variation in the gene content, and H2C3 harbours a plasmid. RBM
is a biofilm knockout strain, and LB and saline are negative controls.
Levade et al., Microbial Genomics 2017;3
11
gene absences, reducing false-positive inference of gene con-
tent variation (Figs S2 and S3). We detected between five
and 103 genes that varied in presence/absence within
patients (Fig. 2; Table 2). Each gene does not necessarily
represent an independent gain/loss event; for example, the
ICE contained 61 genes on a single contig, likely a single
gain/loss event. Even under the conservative assumption
that all gene content variation represents a single gain/loss
event per patient, this still indicates at least one event per
patient.
Some of the putative HGT events could have consequences
for V. cholerae survival and virulence within the host. For
instance, the group of 20 genes acquired by one V. cholerae
isolate within patient H2, likely via a plasmid of Bacteroides
origin, is associated with a twofold reduction in biofilm for-
mation (Fig. 5). Among these 20 genes, we identified an
antibiotic resistance gene, a haloacid dehalogenase protein
that could impact pathogenicity [64], and a FtsY recognition
signal protein that was shown to increase virulence in Strep-
tococcus [65]. Among the genes likely acquired from a
Staphylococcus donor in isolate B1C2, three could poten-
tially be involved in modulation of virulence (Fig. S5,
Table S6). Firstly, a GNAT family acetyltransferase could
promote virulence or increase antibiotic resistance [66, 67].
Secondly, a putative phosphoenolpyruvate phosphotransfer-
ase has been demonstrated to play a role in biofilm forma-
tion in Vibrio [68–70]. Finally, the KdpC gene (a
potassium-transporting ATPase) has been shown to modu-
late virulence inMycobacterium paratuberculosis [71].
Not all gene gain/losses are due to HGT. Many can be
explained by gene deletions, such as phage excision events.
Deletions could explain much of the variation among genes
in categories A and B (Fig. 2), respectively corresponding to
the ICE and Kappa phage. These elements are known to
vary among V. cholerae genomes sampled over larger tem-
poral and geographic scales [72], but here we document
likely excision events during human infection. Genes in cat-
egory D tend to be singletons, present in just a single isolate,
and with taxonomic affiliations well beyond V. cholerae,
including Bacteroides, Staphylococcus, and crAssphage
(Fig. 2). Category D genes are most easily explained by
cross-species HGT, as previously documented by Folster
and colleagues, who identified a Haitian V. cholerae isolate
that gained multidrug resistance through transfer of a plas-
mid from a species of Enterobacteriaceae [61]. Although to
our knowledge, ours is the first description of HGT specifi-
cally between V. cholerae and Bacteroides, the genus
Bacteroides is known to be involved in inter-species and
inter-genus HGT in the human gut [73, 74]. Taken together,
these results are consistent with the human gut being a hot-
spot of HGT [75], sometimes involving pathogens like
V. cholerae. Although we hesitate to speculate on the even-
tual fate of within-patient gene gain/loss events, it appears
that certain events (e.g. in the ICE or kappa phage) persist
long enough to be observed as fixed differences between
patients. The rare cross-species HGT events we observed
were at low frequency (present in just one isolate per
patient), suggesting they are neutral or slightly deleterious
variants that will never attain high frequency – although
their eventual fate is unknown.
Regimes of natural selection inferred from
within-patient point mutations
The low levels of variation (0–3 iSNVs per patient) observed
within cholera infections could be easily confounded with
sequencing errors or mutations occurring during culture
rather than within patients. Therefore, we developed filters
for calling SNVs and gene gain/loss events that yielded zero
variation among control isolates, suggesting low rates of
false-positive variant calls and increasing confidence that
the six total iSNVs (Fig. 1; Table 1) did indeed vary within
patients.
Point mutations detected within cholera patients could be
the result of de novo mutations occurring within the patient,
or a consequence of a co-infection from different strains
that had diverged previous to the infection. Although we
cannot formally exclude co-infections (particularly of low-
frequency strains not detectable by sequencing 8–20 iso-
lates), our results are more consistent with de novomutation
within hosts. Isolates from the same patient were grouped
together on the phylogeny (Fig. 3), suggesting a recent
clonal ancestor. This result is consistent with previous find-
ings that cholera outbreaks are highly clonal [76].
Cycles of transmission from host to host, or from aquatic
environment to host, can induce population bottlenecks,
reducing the effective population size. Based on compari-
sons of distantly related genomes, Ne of V. cholerae has
been estimated to be 4.78108 [77]. This relatively large Ne
reflects the high genetic diversity present in the aquatic
environment, and over long evolutionary time-scales. How-
ever, during transmission and intestinal colonization, the
size of the V. cholerae population experiences drastic bottle-
necks that could temporarily reduce Ne. Abel and colleagues
showed that V. cholerae population sizes in rabbit models of
infection ranged from 105 during the early phases of coloni-
zation to ~102 at the late phases of infection [32]. Our esti-
mates of Ne based on iSNVs give values of 0 to ~10
2,
consistent with population bottlenecks or selective sweeps
purging diversity (Table S1). The infectious dose of V. chol-
erae has been estimated to be 103–108 cells [1]. Our low esti-
mates of Ne indicate that (i) this infectious dose is
genetically homogeneous, or that (ii) any pre-existing diver-
sity is quickly purged by a bottleneck or selective sweep.
In addition to the small within-patient Ne, we found that
the distribution of mutations, physically along the V. chol-
erae genome, and temporally along the phylogeny, could
generally be explained by random neutral simulations (Sup-
plementary Note). However, we identified an excess of NS
mutations in one Haitian patient (H1), suggesting positive
or diversifying selection on V. cholerae within this patient
(Fig. 4). Patient H1, like all patients in this study, suffered
from severe acute cholera, and we do not have access to
Levade et al., Microbial Genomics 2017;3
12
further information about this patient which might explain
the excess of NS mutations. Two of these mutations affected
the same protein, a sensor protein histidine kinase. This
sensor protein histidine kinase (HK) is part of a two-com-
ponent system known as VprAB, which has been shown to
mediate glycine fixation in the lipid A domain of lipopoly-
saccharide molecules, which is necessary for resistance to
the antimicrobial peptide polymyxin B [53]. Another two-
component system, CarRS, is known to confer polymyxin B
resistance, but also to negatively regulate biofilm formation
[56, 57]. Here, we found that derived alleles (presumed de
novo mutations within the host) in the HK VprB did not
appear to affect polymyxin B resistance, but did reduce the
ability of V. cholerae to form biofilms (Fig. 5). It has been
previously suggested that biofilm formation may be benefi-
cial for survival in the aquatic environment, but detrimental
to survival or colonization of mammalian hosts [54, 55].
Therefore, the derived iSNV alleles may have been selected
for reduced biofilm formation.
Our study provides an opportunity to compare V. cholerae
evolutionary dynamics between Bangladesh, where cholera
has been endemic for hundreds or thousands of years [78],
and Haiti, where it was introduced in 2010. Our results sug-
gest that selective pressures on V. cholerae may differ
between Haiti and Bangladesh, as previously proposed [12].
In Bangladesh, we observed an excess of NS mutations
between patients (Table 3), suggest positive selection on
protein sequences between patients, or efficient purifying
selection purging NS mutations within patients. In contrast
to Bangladesh, where zero NS iSNVs were observed, we
observed three NS iSNVs in Haiti, all within the same
patient. Such differences between Haiti and Bangladesh
need confirmation in a larger sample, and if confirmed
could have different explanations. For example, if Haitian
patients are less likely than Bangladeshis to have had prior
exposure and immunity to cholera, perhaps cholera infec-
tions could last longer, or support larger V. cholerae popula-
tion sizes within patients in Haiti, allowing more efficient
positive selection within patients. Further sequencing of
intra-host V. cholerae genomes, ideally in combination with
clinical data on infection durations and outcomes, will be
needed to test this hypothesis.
Conclusion
We have shown that small but measurable changes occur in
the V. cholerae genome during human infection. Changes in
flexible gene content appear to accumulate more quickly
than point mutations, although point mutations may also
be targets of natural selection. Both gene content variation
and point mutations can have consequences for the pheno-
types of within-patient V. cholerae populations, including
clinically- and environmentally-relevant traits like biofilm
formation. Future studies will be necessary to determine the
role of intra-host diversity – particularly in the ICE and
mobile genetic elements – in the evolution of antibiotic
resistance, host adaptation, and the severity of disease in
infected patients.
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